Product Images Anastrozole

This is a description of a medication called Anastrozole, which is only available with a prescription. The medication comes in a box with 5 blister strips, each containing 10 tablets (50 tablets total). Each tablet contains 1 mg of Anastrozole USP. The product warning advises users to keep the medication away from children. The medication should be stored at controlled room temperature. The manufacturer of this medication is Avkare, Inc.*

This appears to be a graph or chart showing disease-free survival in months for two treatments, anastrozole and tamoxifen. The x-axis shows the time in months (ranging from 0 to 90), and the y-axis shows the proportion of patients who are alive and disease-free (ranging from 0 to 1). The two treatments are represented by different colored lines. Additionally, the number of patients at risk for each treatment is listed on the bottom.*

This appears to be a graph showing the disease-free survival rates of patients receiving either anastrozole or tamoxifen treatment over a period of 90 months. The x-axis shows the time in months, while the y-axis shows the proportion of patients who were disease-free and alive. The graph seems to suggest that anastrozole might be a more effective treatment, as the survival rate for patients who received it was consistently higher than that of patients who received tamoxifen.*

This appears to be a graph showing the "Proportion Event Free" over time in months, for a study on randomized treatment of anastrozole and tamoxifen. The graph includes a legend indicating the treatments being compared, and notes that the vertical axis has been truncated to improve clarity. There are also numbered markers along the x-axis indicating time points where the number of patients at risk have been recorded.*

This appears to be a graph displaying the time to progression (in months) for a randomized treatment of anastrozole compared to tamoxifen. The graph shows that the proportion of patients who progressed did not increase significantly over time for either treatment. The text includes a table showing the number of patients at risk for each time point.*

This seems to be an incomplete data chart displaying different treatments of a medical condition over a span of 40 months. There are two types of treatments given, ANASTROZOLE, and TAMOXIFEN, and the chart displays the time to progression for both treatments. However, there isn't enough context to determine the medical condition being treated, the details of the treatments, and the source of the data. Therefore, this description is limited to just the interpretation of the given text.*